NeuroOne Medical Technologies Corporation Proceeds from Issuance of Private Placement
NeuroOne Medical Technologies Corporation (NMTC) reported Proceeds from Issuance of Private Placement of $836.78 thousand for the 12-month period ending 2024-09-30, per its 10-K filed 2024-12-17.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfPrivatePlacement · last filed 2024-12-17
- NeuroOne Medical Technologies Corporation proceeds from issuance of private placement for the quarter ending 2019-09-30 was $84.63K.
- NeuroOne Medical Technologies Corporation proceeds from issuance of private placement for the quarter ending 2019-06-30 was $708.55K.
- NeuroOne Medical Technologies Corporation proceeds from issuance of private placement for the quarter ending 2019-03-31 was $3.73M.
- NeuroOne Medical Technologies Corporation proceeds from issuance of private placement for the quarter ending 2018-12-31 was $40.00K.
- NeuroOne Medical Technologies Corporation proceeds from issuance of private placement for fiscal 2024 was $836.78K, a 86.14% decline from fiscal 2023.
- NeuroOne Medical Technologies Corporation proceeds from issuance of private placement for fiscal 2023 was $6.04M.
- NeuroOne Medical Technologies Corporation proceeds from issuance of private placement for fiscal 2019 was $4.56M.
| Period end | Proceeds from Issuance of Private Placement 1 month | Proceeds from Issuance of Private Placement 3 month | Proceeds from Issuance of Private Placement 3 month as first filed | Proceeds from Issuance of Private Placement 6 month | Proceeds from Issuance of Private Placement 9 month | Proceeds from Issuance of Private Placement 12 month |
|---|---|---|---|---|---|---|
| 2024-09-30 | $836.78K 10-K · filed 2024-12-17 | |||||
| 2023-09-30 | $6.04M 10-K · filed 2024-12-17 | |||||
| 2019-09-30 | $84.63K derived: 10-K 12 month − 10-Q 9 month · filed 2019-12-20 | $793.18K derived: sum of 2 quarters · filed 2019-12-20 | $4.52M derived: sum of 3 quarters · filed 2019-12-20 | $4.56M 10-K · filed 2019-12-20 | ||
| 2019-06-30 | $708.55K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-08-14 | $4.44M derived: sum of 2 quarters · filed 2019-08-14 | $4.48M 10-Q · filed 2019-08-14 | |||
| 2019-03-31 | $3.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-10 | $3.77M 10-Q · filed 2019-05-10 | ||||
| 2018-12-31 | $40.00K 10-Q · filed 2020-02-14 | $601.65K 10-Q · filed 2019-02-14 | ||||
| 2018-09-30 | $824.89K 10-K · filed 2019-12-20 | |||||
| 2018-07-31 | $1.11M 10-KT · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B |